Neuroendocrine tumor lenitive market has been growing rapidly in the recent past due to rising incidence of NET in the world. New diagnostic technologies and molecular markers detect diseases before the onset of symptoms, increasing the need for therap Author ‘s note The development of highly sensitive imaging and biomarker detection technologies contributes to the early diagnosis of diseases which have been never manifested, and thus, increases the need for adequate treatment.

Agitation in Delirium Management Market Size Was Valued at USD 235.23 Million in 2023, and is Projected to Reach USD 352.6 Million by 2032, Growing at a CAGR of 4.6% From 2024-2032.